Health System

ASHP's latest survey of hospital pharmacists shows that they are increasingly a force to be reckoned with.

Entereg is a new drug to help hospitalized patients who have undergone abdominal surgery restore their bowel functions.

ASCP launches assisted living manual.

CVS Caremark is partnering with Google on the launch of Google Health to provide consuemrs with secure access to their health information.

Bayer has reformulated Leukine without EDTA, which has been linked with fainting.

Medicis issues recall of two lots of antibiotic Solodyn.

The Cancer Prevention Coalition is urging the FDA in a petition to put a cancer warning on cosmetic talc powder products.

Winn-Dixie supermarket pharmacy is making it easier for customers to use their health savings account and flexible spending account cards.

Bayer will remove remaining supplies of Trasylol from market following the publication of negative study results.

Consumers Union is urging the FDA to move ahead with requiring TV ads for Rx drugs to include a toll free number and a Web site address to report serious side effects from presciption drugs.

Faced with increased costs of supplying uncontaminated heparin, APP Pharmaceuticals adjusts the cost of its product.

A new report from Avalere Health has found that many drugs were dropped from CMS' 2008 Part D formulary files.

NACDS applauded action by the House Judiciary Committee to address excessive fees imposed by credit card companies for retail transactions.

Aetna reports that its MTM programs have worked due to pharmacist interventions

An expert gives drug plans advice on how to pass a Medicare Part D audit

A new Medco study of insured patients show that more people are taking drugs for chronic diseases.

NACDS testifies on impact of Medicare and Medicaid regulations on pharmacies.

Two supermarket chains follow in Wal-Mart's footsteps by offering 90-day supplies of generics at $10.

Several lots of Doxil, Procrit, and Remicade have been stolen, prompting the manufacturers to issue a voluntary withdrawal of the lots affected.

Kroger and Wal-Mart recently announced enhancments to their in store pharmaices $4 generic drug programs.

Novalar Pharmaceuticals granted approval for first dental anesthesia reversal agent, phentolamine mesylate (OraVerse).

Warner Chilcott and Leo Pharma announc the FDA approval of a new combination suspension for psoriasis of the scalp.

A new Pennsylvania law sets up a voluntary drug repository program for cancer patients.

A new study funded by GlaxoSmithKline found that Type 2 diabetics who have to shell out higher copays are more likely to not take their drugs as indicated.

Several healthcare groups are planning to stage demonstrations on May 30 over FDA's decision not to approve Provenge for prostate cancer.